Differential Effects of Chronic Ethanol Use on Mouse Neuronal and Astroglial Metabolic Activity

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2023 Apr 17

PMID 37069415

Authors

Unis Ahmad Bhat

Sreemantula Arun Kumar

Sumana Chakravarty

Anant Bahadur Patel

Arvind Kumar

Affiliations

Soon will be listed here.

Abstract

Chronic alcohol use disorder, a major risk factor for the development of neuropsychiatric disorders including addiction to other substances, is associated with several neuropathology including perturbed neuronal and glial activities in the brain. It affects carbon metabolism in specific brain regions, and perturbs neuro-metabolite homeostasis in neuronal and glial cells. Alcohol induced changes in the brain neurochemical profile accompany the negative emotional state associated with dysregulated reward and sensitized stress response to withdrawal. However, the underlying alterations in neuro-astroglial activities and neurochemical dysregulations in brain regions after chronic alcohol use are poorly understood. This study evaluates the impact of chronic ethanol use on the regional neuro-astroglial metabolic activity using H-[C]-NMR spectroscopy in conjunction with infusion of [1,6-C]glucose and sodium [2-C]acetate, respectively, after 48 h of abstinence. Besides establishing detailed C labeling of neuro-metabolites in a brain region-specific manner, our results show chronic ethanol induced-cognitive deficits along with a reduction in total glucose oxidation rates in the hippocampus and striatum. Furthermore, using [2-C]acetate infusion, we showed an alcohol-induced increase in astroglial metabolic activity in the hippocampus and prefrontal cortex. Interestingly, increased astroglia activity in the hippocampus and prefrontal cortex was associated with a differential expression of monocarboxylic acid transporters that are regulating acetate uptake and metabolism in the brain.

References

Koob G . The dark side of emotion: the addiction perspective. Eur J Pharmacol. 2015; 753:73-87. PMC: 4380644. DOI: 10.1016/j.ejphar.2014.11.044. View

Koob G . The Dark Side of Addiction: The Horsley Gantt to Joseph Brady Connection. J Nerv Ment Dis. 2016; 205(4):270-272. PMC: 6135258. DOI: 10.1097/NMD.0000000000000551. View

Wise R, Koob G . The development and maintenance of drug addiction. Neuropsychopharmacology. 2013; 39(2):254-62. PMC: 3870778. DOI: 10.1038/npp.2013.261. View

Fama R, Le Berre A, Hardcastle C, Sassoon S, Pfefferbaum A, Sullivan E . Neurological, nutritional and alcohol consumption factors underlie cognitive and motor deficits in chronic alcoholism. Addict Biol. 2017; 24(2):290-302. PMC: 6003831. DOI: 10.1111/adb.12584. View

Bruijnen C, Dijkstra B, Walvoort S, Markus W, VanDerNagel J, Kessels R . Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 2019; 38(4):435-442. PMC: 6593747. DOI: 10.1111/dar.12922. View

Le Berre A, Fama R, Sullivan E . Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research. Alcohol Clin Exp Res. 2017; 41(8):1432-1443. PMC: 5531758. DOI: 10.1111/acer.13431. View

White A, Matthews D, Best P . Ethanol, memory, and hippocampal function: a review of recent findings. Hippocampus. 2000; 10(1):88-93. DOI: 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L. View

Gilpin N, Herman M, Roberto M . The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry. 2014; 77(10):859-69. PMC: 4398579. DOI: 10.1016/j.biopsych.2014.09.008. View

Koob G, Buck C, Cohen A, Edwards S, Park P, Schlosburg J . Addiction as a stress surfeit disorder. Neuropharmacology. 2013; 76 Pt B:370-82. PMC: 3830720. DOI: 10.1016/j.neuropharm.2013.05.024. View

10.

Wang J, Du H, Jiang L, Ma X, de Graaf R, Behar K . Oxidation of ethanol in the rat brain and effects associated with chronic ethanol exposure. Proc Natl Acad Sci U S A. 2013; 110(35):14444-9. PMC: 3761635. DOI: 10.1073/pnas.1306011110. View

11.

Yang W, Singla R, Maheshwari O, Fontaine C, Gil-Mohapel J . Alcohol Use Disorder: Neurobiology and Therapeutics. Biomedicines. 2022; 10(5). PMC: 9139063. DOI: 10.3390/biomedicines10051192. View

12.

Chastain G . Alcohol, neurotransmitter systems, and behavior. J Gen Psychol. 2006; 133(4):329-35. DOI: 10.3200/GENP.133.4.329-335. View

13.

Valenzuela C . Alcohol and neurotransmitter interactions. Alcohol Health Res World. 1997; 21(2):144-8. PMC: 6826822. View

14.

Jagannathan N, Desai N, Raghunathan P . Brain metabolite changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging. 1996; 14(5):553-7. DOI: 10.1016/0730-725x(96)00048-3. View

15.

Enculescu C, Kerr E, Yeo K, Schenk G, Fortes M, Schulz B . Proteomics Reveals Profound Metabolic Changes in the Alcohol Use Disorder Brain. ACS Chem Neurosci. 2019; 10(5):2364-2373. DOI: 10.1021/acschemneuro.8b00660. View

16.

Tiwari V, Veeraiah P, Subramaniam V, Patel A . Differential effects of ethanol on regional glutamatergic and GABAergic neurotransmitter pathways in mouse brain. J Neurochem. 2013; 128(5):628-40. DOI: 10.1111/jnc.12508. View

17.

Hyder F, Patel A, Gjedde A, Rothman D, Behar K, Shulman R . Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab. 2006; 26(7):865-77. DOI: 10.1038/sj.jcbfm.9600263. View

18.

Patel A, de Graaf R, Mason G, Kanamatsu T, Rothman D, Shulman R . Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. J Cereb Blood Flow Metab. 2004; 24(9):972-85. DOI: 10.1097/01.WCB.0000126234.16188.71. View

19.

Gruetter R, Seaquist E, Ugurbil K . A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am J Physiol Endocrinol Metab. 2001; 281(1):E100-12. DOI: 10.1152/ajpendo.2001.281.1.E100. View

20.

Lebon V, Petersen K, Cline G, Shen J, Mason G, Dufour S . Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci. 2002; 22(5):1523-31. PMC: 2995528. View